Evidence-Based Complementary and Alternative Medicine / 2020 / Article / Tab 3

Review Article

Efficacy of Lianhua Qingwen Compared with Conventional Drugs in the Treatment of Common Pneumonia and COVID-19 Pneumonia: A Meta-Analysis

Table 3

Sensitivity analysis of common pneumonia and COVID-19 pneumonia.

SubjectEfficacy indexEffect value95% CI

Common pneumoniaFlu-like symptomsWMD = −1.81−2.17, −1.47
SputumWMD = −1.10−1.94, −0.52
Pulmonary ralesWMD = −2.03−2.87, −1.21
Pulmonary imaging improvementWMD = −1.88−2.45, −1.37
Curative effectOR = 3.652.69, 5.13
Healing periodWMD-1.68−2.80, −0.53
Adverse reactionOR = 0.750.50, 1.19

COVID1-19 pneumoniaFlu-like symptomsOR = 3.182.18, 4.63
SputumOR = 4.300.36, 47.40
Shortness of breathOR = 10.622.80, 66.79
BreathlessnessOR = 4.810.29.42.01
Chest tightnessOR = 3.020.77, 28.11
Pulmonary imaging improvementOR = 1.770.95, 3.41
Curative effectOR = 2.491.58, 4.85
Healing periodWMD = −2.06−4.01, 0.01
Conversion of severe casesOR = 0.460.10, 0.92

AllAdverse reactionsOR = 0.740.54, 1.05

The sensitivity analysis results indicated that deleting individual studies would change the combined results of the meta-analysis.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.